Paul Lizzul
Chief Tech/Sci/R&D Officer bei ANAPTYSBIO, INC.
Vermögen: 227 857 $ am 31.03.2024
Profil
Paul F.
Lizzul is currently the Chief Medical Officer at AnaptysBio, Inc. and a Member of the American Academy of Dermatology.
He previously worked as the Executive Medical Director at Amgen, Inc., Senior Medical Director at Kythera Biopharmaceuticals LLC, Assistant Professor at Tufts University School of Medicine, and Chief Medical Officer at Sienna Biopharmaceuticals, Inc. Lizzul holds a doctorate from the University of Medicine & Dentistry of New Jersey, an undergraduate degree from Rensselaer Polytechnic Institute, a graduate degree from Robert Wood Johnson Medical School, and an MBA from Rutgers Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ANAPTYSBIO, INC.
0,04% | 08.01.2024 | 10 118 ( 0,04% ) | 227 857 $ | 31.03.2024 |
Aktive Positionen von Paul Lizzul
| Unternehmen | Position | Beginn |
|---|---|---|
| ANAPTYSBIO, INC. | Chief Tech/Sci/R&D Officer | 31.07.2020 |
American Academy of Dermatology
 American Academy of Dermatology Miscellaneous Commercial ServicesCommercial Services American Academy of Dermatology is the largest and most influential dermatology group in the United States. The private company is based in the United States and has subsidiaries in various locations. The American company provides resources on membership, education, practice management, publications, and clinical care for dermatologists. The company also offers information for patients and the public on skin, hair, and nail conditions. Elizabeth Usher has been the CEO of the company since 2019. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Paul Lizzul
| Unternehmen | Position | Ende |
|---|---|---|
| KYTHERA BIOPHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 01.01.2016 |
| Tufts University School of Medicine | Corporate Officer/Principal | 01.01.2012 |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | - |
| SIENNA BIOPHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Paul Lizzul
| University of Medicine & Dentistry of New Jersey | Doctorate Degree |
| Rensselaer Polytechnic Institute | Undergraduate Degree |
| Robert Wood Johnson Medical School | Graduate Degree |
| Rutgers Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| ANAPTYSBIO, INC. | Health Technology |
| SIENNA BIOPHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Kythera Biopharmaceuticals LLC
 Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kythera Biopharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market. The company was founded by Jay Edward Birnbaum, Amit D. Munshi, Nathaniel Eames David, and Keith R. Leonard, Jr. on June 3, 2004 and is headquartered in Westlake, CA. | Health Technology |
American Academy of Dermatology
American Academy of Dermatology Miscellaneous Commercial ServicesCommercial Services American Academy of Dermatology is the largest and most influential dermatology group in the United States. The private company is based in the United States and has subsidiaries in various locations. The American company provides resources on membership, education, practice management, publications, and clinical care for dermatologists. The company also offers information for patients and the public on skin, hair, and nail conditions. Elizabeth Usher has been the CEO of the company since 2019. | Commercial Services |
